The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksAmedeo Afp Regulatory News (AA4)

Share Price Information for Amedeo Afp (AA4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.00
Bid: 39.50
Ask: 40.50
Change: 0.40 (1.01%)
Spread: 1.00 (2.532%)
Open: 39.60
High: 40.00
Low: 39.60
Prev. Close: 39.60
AA4 Live PriceLast checked at -
Amedeo Air Four Plus is an Investment Trust

To obtain income returns and a capital return for its Shareholders by acquiring, leasing and then selling aircraft.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Factsheet & Dividend Update

5 May 2021 07:00

RNS Number : 5321X
Amedeo Air Four Plus Limited
05 May 2021
 

5 May 2021

 

AMEDEO AIR FOUR PLUS LIMITED (the "Company")(LSE: AA4, LEI: 21380056PDNOTWERG107)Factsheet & Dividend Update

The Company announces that its quarterly factsheet for the period to 31 March 2021 is now available on its website at http://www.aa4plus.com. An extract from the Chairman's statement within the factsheet is reproduced below.

"The past year has been the most difficult in aviation outside wartime. We have had to take decisions and actions based in part on governmental actions and predictions which have proved to be either wrong or misleading, such as the prediction that, after a short sharp downturn in Q2 and Q3, there would be a resurgence in Q4 when vaccines would hopefully restore international travel. In fact, Q1 2021 was worse than Q4 2020 and the more cautious predictions that such travel would take at least until 2023 to achieve historic growth levels seem more likely.

The process of rehabilitation of Thai Airways continues and our assumption that it would be the end of Q2 2021 before resolution was achieved remains the most likely outcome. The Rehabilitation Plan was presented to the Official Receiver on 2 March 2021 and it is expected that the Official Receiver will approve the Plan with creditor groups on 12 May 2021, following which the Board intends to make a further announcement to update shareholders. Subject to the timely approval of the Plan, the Board anticipates that the Company's new arrangements with Thai Airways and, crucially, the restructuring of debt with its lenders, will be documented and effective in June / July 2021.

Although unpopular, the Board's decision that preservation of liquidity was crucial to the Company's task of seeing out the Covid crisis has proven to be the correct one. The Board has also taken the decision to suspend quarterly dividends until the rehabilitation of Thai Airways and agreement with the Company's lenders are complete which, as set out above, is currently expected in June/July 2021. The Board is committed to reinstating a sustainable dividend policy as soon as is practicable.

Shareholders will be aware that we have maintained interest payments to our Thai lenders, having entered into forbearance agreements with these banks, as we believe that the eventual resumption of payments from Thai Airways and an agreement on long term debt restructuring will result in the Company being in a far stronger position than allowing the debt to default and resulting in the repossession of the Thai aircraft.

On a brighter note, Emirates has faithfully performed its obligations, has identified three out of our six A380 aircraft for upgrade to Premium Economy seating and has re-affirmed its support for the hub and spoke model and for the A380 within its fleet even whilst around 100 of their A380 aircraft remain grounded. This is without, it must be said, specifying actual fleet numbers and whilst at the same time appearing to see an equally positive business case for twin widebody operations on routes which cannot support A380 or indeed 777X operation. Their enthusiastic adoption of a fast vaccination programme in the UAE, trialling of the IATA Travel Pass initiative and fast testing and immigration procedures seems to be the way that, slowly but surely, and only when domestic travel has first restored itself, international travel will return.

Finally, the Company announces that a formal search for a new independent non-executive director has commenced and a further announcement will be made in due course."

 For further information, please contact:

JTC Fund Solutions (Guernsey) Limited

+44 (0) 1481 702 400

 Liberum Capital Limited

Chris Clarke / Darren Vickers / Owen Matthews

+44 (0) 20 3100 2000

 

About the Company

The Company is a Guernsey-domiciled company, with shares admitted to trading on the Specialist Fund Segment of the London Stock Exchange's Main Market (LSE: AA4).

The Company's investment objective is to obtain income returns and a capital return for its Shareholders by acquiring, leasing and then selling aircraft.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDZGGKVDKGMZM
Date   Source Headline
8th May 20247:00 amRNSFactsheet
2nd May 202412:04 pmRNSHolding(s) in Company
1st May 20247:00 amRNSDirectorate Change
2nd Apr 202410:57 amRNSDividend Declaration
28th Mar 20249:21 amRNSDirectorate Change
13th Feb 20247:00 amRNSFactsheet
11th Jan 20241:56 pmRNSDividend Declaration
20th Dec 20237:00 amRNSHalf-year Report
8th Dec 20234:30 pmRNSResult of AGM
20th Nov 20237:00 amRNSNotice of AGM
16th Nov 20232:24 pmRNSHolding(s) in Company
19th Oct 20237:00 amRNSFACTSHEET
3rd Oct 20237:00 amRNSDividend Declaration
11th Aug 20237:00 amRNSFactsheet and Investor Call
31st Jul 20237:00 amRNSAnnual Financial Report
24th Jul 20235:08 pmRNSDirector/PDMR Shareholding
24th Jul 20235:08 pmRNSDirector/PDMR Shareholding
3rd Jul 202311:17 amRNSDividend Declaration
24th May 20236:03 pmRNSHolding(s) in Company
3rd May 20237:00 amRNSFactsheet
4th Apr 20237:00 amRNSDividend Declaration
1st Mar 20237:00 amRNSCompletion Partial Compulsory Redemption & TVR
22nd Feb 20239:05 amRNSSecond Price Monitoring Extn
22nd Feb 20239:00 amRNSPrice Monitoring Extension
22nd Feb 20237:01 amRNSReturn of Capital and Increased Quarterly Dividend
22nd Feb 20237:00 amRNSFactsheet
19th Jan 20237:00 amRNSDirectorate Change
13th Jan 20234:46 pmRNSHolding(s) in Company
5th Jan 20237:00 amRNSDividend Declaration
14th Dec 20227:00 amRNSHalf-year Report
13th Dec 202212:38 pmRNSResult of AGM
28th Nov 20224:52 pmRNSNotice of AGM
21st Nov 20222:37 pmRNSFactsheet
24th Oct 20225:49 pmRNSHolding(s) in Company
6th Oct 20225:08 pmRNSDividend Declaration
5th Aug 20227:00 amRNSAnnual Financial Report - Correction
4th Aug 20227:00 amRNSInvestor Call
29th Jul 20227:00 amRNSAnnual Financial Report
5th Jul 20227:00 amRNSDividend Declaration
7th Jun 20226:02 pmRNSHolding(s) in Company
24th May 20223:41 pmRNSHolding(s) in Company
24th May 20223:37 pmRNSHolding(s) in Company
18th May 20222:09 pmRNSDirector/PDMR Shareholding
4th May 20226:25 pmRNSFactsheet
12th Apr 202212:10 pmRNSDirector/PDMR Shareholding
11th Apr 20227:00 amRNSDividend Declaration
1st Apr 20221:37 pmRNSDirector/PDMR Shareholding
18th Jan 20229:42 amRNSDirector/PDMR Shareholding
4th Jan 202212:35 pmRNSDividend Reinstatement and Declaration
23rd Dec 20217:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.